Peter B. Jahrling

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.

Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.

Hemorrhagic fever viruses as biological weapons: medical and public health management.

Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.

Evaluation in nonhuman primates of vaccines against Ebola virus.

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.

Smallpox research activities: U.S. interagency collaboration, 2001.

Detection of antibodies against the four subtypes of ebola virus in sera from any species using a novel antibody-phage indicator assay.

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

Commentary on Dr. Alan zelicoff's Analysis of the Aralsk outbreak (No. 4).

Real-time PCR assay to detect smallpox virus.

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.

Detection and identification of Variola virus in fixed human tissue after prolonged archival storage.

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Towards a vaccine against Ebola virus.

Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms.

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.

Interferon-beta 1a and SARS coronavirus replication.

Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques.

Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.

The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks.

Exotic emerging viral diseases: progress and challenges.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Development of a new vaccine for the prevention of Lassa fever.

Virulence differences between monkeypox virus isolates from West Africa and the Congo basin.

Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein.

Ebola and Marburg viruses: pathogenesis and development of countermeasures.

Countermeasures to the bioterrorist threat of smallpox.

Cynomolgus macaque as an animal model for severe acute respiratory syndrome.

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.

Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.

MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever.

Viral hemorrhagic fevers.

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.

Panmicrobial oligonucleotide array for diagnosis of infectious diseases.

The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever.

Dynamics of oliveros virus infection in rodents in central Argentina.

Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.

Framework for leadership and training of Biosafety Level 4 laboratory workers.

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.

Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers.

Inhibition of monkeypox virus replication by RNA interference.

Clarification and guidance on the proper usage of virus and virus species names.

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.

A proposal to change existing virus species names to non-Latinized binomials.

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.

Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route.

Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.

Molecular imaging of influenza and other emerging respiratory viral infections.

Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins.

Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.

Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.

Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.

Intrabronchial inoculation of cynomolgus macaques with cowpox virus.

Progression of pathogenic events in cynomolgus macaques infected with variola virus.

Evaluation of monkeypox disease progression by molecular imaging.

Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease.

Evaluation of perceived threat differences posed by filovirus variants.

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.

Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox virus.

Antiviral activity of the EB peptide against zoonotic poxviruses.

Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.

A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.

The International Code of Virus Classification and Nomenclature (ICVCN): proposal to delete Rule 3.41.

Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.

Clinical management of filovirus-infected patients.

Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection.

Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.

The International Code of Virus Classification and Nomenclature (ICVCN): proposal for text changes for improved differentiation of viral taxa and viruses.

Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates.

Nyamiviridae: proposal for a new family in the order Mononegavirales.

Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.

Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus.

Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions.

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.

Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques.

Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays.

ABSL-4 aerobiology biosafety and technology at the NIH/NIAID integrated research facility at Fort Detrick.

Systems kinomics for characterizing host responses to high-consequence pathogens at the NIH/NIAID Integrated Research Facility-Frederick.

The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens.

Variola virus archives: a new century, a new approach.

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.

Two novel simian arteriviruses in captive and wild baboons (Papio spp.).

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Genome Sequences of Simian Hemorrhagic Fever Virus Variant NIH LVR42-0/M6941 Isolates (Arteriviridae: Arterivirus).

Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses a clathrin-mediated endocytosis-like pathway.

CD26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-CoV) infection and evolution of persistent infection.

Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran.

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014.

Taxonomic reorganization of the family Bornaviridae.

Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine.

Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis.

Characterization of the host response to pichinde virus infection in the Syrian golden hamster by species-specific kinome analysis.

Lack of effect of lamivudine on Ebola virus replication.

Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease.

Middle East respiratory syndrome: obstacles and prospects for vaccine development.

State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus.

Generation and characterization of large-particle aerosols using a center flow tangential aerosol generator with a non-human-primate, head-only aerosol chamber.

Historical Outbreaks of Simian Hemorrhagic Fever in Captive Macaques Were Caused by Distinct Arteriviruses.

The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PET.

Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus.

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease.

Use of Existing Diagnostic Reverse-Transcription Polymerase Chain Reaction Assays for Detection of Ebola Virus RNA in Semen.

Modeling [(18)F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge.

Reorganization and expansion of the nidoviral family Arteriviridae.

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012.

Divergent Simian Arteriviruses Cause Simian Hemorrhagic Fever of Differing Severities in Macaques.

Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques - A model of severe pneumonia.

Specific Detection of Two Divergent Simian Arteriviruses Using RNAscope In Situ Hybridization.

Ebola virus disease candidate vaccines under evaluation in clinical trials.

Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease.

Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells.

Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform.

Neglected filoviruses.

Genomic Characterization of the Genus Nairovirus (Family Bunyaviridae).

Essentials of filoviral load quantification.

Reduced evolutionary rate in reemerged Ebola virus transmission chains.

An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.

Overlooking the importance of immunoassays - Authors' reply.